The emerging role of ricin A-chain immunotoxins in leukemia and lymphoma

Current Topics in Microbiology and Immunology

Volumn 234, Issue , 1998, Pages 13-33

  Engert, A ^a   Sausville, E A ^b   Vitetta, E ^c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; ANTIBODY CONJUGATE; B LYMPHOCYTE ANTIBODY; CANCER ANTIBODY; CD19 ANTIGEN; CD22 ANTIGEN; CD5 ANTIGEN; CHIMERIC ANTIBODY; DIPHTHERIA TOXIN; ENDOGLIN; GAMMA INTERFERON; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOTOXIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ANTIBODY RICIN A CHAIN IMMUNOTOXIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 260 F 9 RICIN A CHAIN IMMUNOTOXIN; MONOCLONAL ANTIBODY CD5 RICIN A CHAIN IMMUNOTOXIN; MONOCLONAL ANTIBODY HD 37 RICIN A CHAIN IMMUNOTOXIN; MONOCLONAL ANTIBODY RFB 4 RICIN A CHAIN IMMUNOTOXIN; OKT 4; RECOMBINANT RICIN A CHAIN IMMUNOTOXIN; RICIN A; RICIN ANTIBODY; RICINUS COMMUNIS EXTRACT; UNCLASSIFIED DRUG;

ACROCYANOSIS; CANCER CELL DESTRUCTION; CAPILLARY LEAK SYNDROME; CLINICAL TRIAL; DYSPNEA; FATIGUE; HUMAN; HUMAN CELL; HYPOALBUMINEMIA; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LUNG EDEMA; LYMPHOMA; MINIMAL RESIDUAL DISEASE; MUSCLE HYPOTONIA; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; SENSORIMOTOR NEUROPATHY; SOLID TUMOR; TACHYCARDIA;

ANIMALIA; RICINUS COMMUNIS;

EID: 0031838566     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-72153-3_2     Document Type: Review

References (12)

1. Amlot PL, Stone MJ, Cunningham D, Fay J, Newman J, Collins R, May R, McCarthy M, Richardson J, Ghetie V et al (1993) A Phase I study of an anti-CD22-deglycosylated ricin A-chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood 82:2624-2633
2. Baluna R, Getie V, Oppenhimer-Marks N, Vitetta ES (1995) The binding of ricin A-chain immunotoxin to fibronectin: possible implications for vascular leak syndrome in immunotoxin-treated patients. 4th international symposium on immunotoxins, p 144
3. Baluna R, Sausville EA, Stone MJ, Stetler-Stevenson MA, Uhr J, Vitetta ES (1996) Decreases in levels of serum fibronectin predict the severity of vascular leak syndrome in patients treated with ricin A-chain-containing immunotoxins. Clin Cancer Res 2:1705-1712
4. Barbas CF III, Amberg W, Simonesits A et al (1993) Selection of human anti-hapten antibodies from semisynthetic libraries. Gene 137:57-62
5. Bell KD, Ramilo O, Vitetta ES (1993) Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus. Proc Natl Acad Sci USA 90:1411-1415
6. Better M, Bernhard SL, Lei SP, Fishwild DM, Lane JA, Carroll SF, Horwitz AH (1993) Potent anti-cd5 ricin-A-chain immunoconjugates from bacterially produced fab' and f(ab')2. Proc Natl Acad Sci USA 90:457-461
7. Bjorn MJ, Ring D, Frankel A (1985) Evaluation of monoclonal antibodies for the development of breast cancer immunotoxins. Cancer Res 45:1214-1221
8. Blakey DC, Thorpe PE (1988) An overview of therapy with immunotoxins containing ricin or its A-chain. Antibody Immunoconj Radiopharm 1:1-16
9. Blakey DC, Watson GJ, Knowles PP, Thorpe PE (1987) Effect of chemical deglycosylation of ricin A-chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A-chain and anti-Thy 1.1 antibody. Cancer Res 47:947-952
10. Blakey DC, Skilleter DN, Price RJ, Thorpe PE (1988) Uptake of native and deglycosylated ricin A-chain immunotoxins by mouse liver parenchymal and non-parenchymal cells in vitro and in vivo. Biochim Biophys Acta 968:172-178
11. Bourrie BJ, Casellas P, Blythman HE, Jansen FK (1986) Study of the plasma clearance of antibody-ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A-chain that mediate rapid clearance of the immunotoxin. Eur J Biochem 155:1-10
12. Burrows FJ, Thorpe PE (1993) Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc Natl Acad Sci USA 90:8996-9000